Breaking News

How biotech’s wealthiest outsider led Summit to victory

September 9, 2024
Wikimedia Commons

STAT+ | With a win in lung cancer, biotech's wealthiest outsider surfs to new heights

Summit's lung cancer treatment has wowed researchers. The CEO behind it is a living challenge to the assumptions of many in biotech.

By Matthew Herper


STAT+ | Relay discloses encouraging results for experimental breast cancer treatment

Relay is planning a late-stage trial comparing its breast cancer drug to a rival treatment from AstraZeneca.

By Angus Chen


Apple pushes into sleep apnea detection but health care integration remains unclear

Apple Watch's new sleep apnea feature will use onboard sensors to detect the dangerous disorder where people have interrupted breathing.

By Mario Aguilar



Almas Eftekhari, a 40-year-old Lyme disease advocate, shrugged off her first, super-mild bout of Covid in August of 2023. But a couple of months later, she crashed with symptoms that moved around her body. Eftekhari has had to stop working due to her illness and lives with her parents in Fairfax, Va.
Lexey Swall for STAT

Medicine struggles to define chronic Lyme. Long Covid has only made it harder

With patients and doctors challenged by overlapping symptoms, researchers are seeking biomarkers and devising "cross-illness" trials.

By Isabella Cueto and Alia Sajani


STAT+ | RayzeBio, Dice alums raise $370 million for new autoimmune startup

San Diego-based Candid Therapeutics, helmed by former RayzeBio CEO Ken Song, will test two promising autoimmune drug candidates.

By Allison DeAngelis


Biden administration finalizes rules to ensure insurers pay for mental health care 

New regulations seek to achieve parity in coverage for conditions like depression and addiction, without new enforcement mechanisms.

By Lev Facher


Alex Davidson/Getty Images

How Paralympic athletes are helping science learn more about neuropathic pain

Published in BMJ Open Sport and Exercise, the study looked at athletes with spinal cord injuries to better understand neuropathic pain.

By Timmy Broderick


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying Daily Recap? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2024, All Rights Reserved.

No comments